LRRK2 and inflammatory bowel disease: Genome‐wide association studies have connected LRRK2 locus polymorphisms with increased risk of immune diseases such as systemic lupus erythematosus [44], Crohn's disease [45], and inflammatory bowel disease [46] and with susceptibility to multibacillary leprosy [47].